Phase II study of mitolactol in metastatic malignant melanoma.

Simmonds, M A

Phase II study of mitolactol in metastatic malignant melanoma. [electronic resource] - Cancer treatment reports Jan 1985 - 65-7 p. digital

Publication Type: Journal Article

0361-5960


Adult
Aged
Bone Marrow--drug effects
Drug Evaluation
Female
Hemoglobins--analysis
Humans
Leukocyte Count
Male
Melanoma--drug therapy
Middle Aged
Mitolactol--adverse effects
Neoplasm Metastasis
Platelet Count